These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8649301)
1. Diabetes and hypertension. Australian Diabetes Society position statement. Mogyorosi A; Ziyadeh FN Med J Aust; 1996 May; 164(9):571-2. PubMed ID: 8649301 [No Abstract] [Full Text] [Related]
2. Renal diseases in diabetes mellitus. Kumar PD; Rajaratnam K J Indian Med Assoc; 1997 Jul; 95(7):426-8. PubMed ID: 9425845 [No Abstract] [Full Text] [Related]
3. [Arterial hypertension and diabetes mellitus: value of converting enzyme inhibitors]. Passa P Bull Acad Natl Med; 1988 Feb; 172(2):205-10. PubMed ID: 3042105 [No Abstract] [Full Text] [Related]
4. Renoprotective role of ACE inhibitors in diabetic nephropathy. Mogensen CE Br Heart J; 1994 Sep; 72(3 Suppl):S38-45. PubMed ID: 7946802 [No Abstract] [Full Text] [Related]
5. Should Angiotensin converting enzyme inhibitors be used in children with type 1 diabetes and microalbuminuria? Almerie MQ; Williams RM; Acerini CL Arch Dis Child; 2008 Jul; 93(7):633-5. PubMed ID: 18285389 [No Abstract] [Full Text] [Related]
10. Renoprotection with antihypertensive agents. Fournier A; Presne C; Makdassi R; Mazouz H; Choukroun G Lancet; 2002 May; 359(9318):1694-5. PubMed ID: 12020553 [No Abstract] [Full Text] [Related]
11. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Basi S; Lewis JB Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288 [TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: are we making progress in delaying renal failure? Barnes CC Clin Biochem; 1993 Aug; 26(4):318-9. PubMed ID: 8242896 [No Abstract] [Full Text] [Related]
15. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control]. Shionoiri H; Yasuda G; Takizawa T; Shionoiri F Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741 [No Abstract] [Full Text] [Related]
16. Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy. Cziraky MJ; Mehra IV; Wilson MD; Bakris GL Ann Pharmacother; 1996; 30(7-8):791-801. PubMed ID: 8826564 [TBL] [Abstract][Full Text] [Related]
17. [Why does the patient lose protein? The state of the vessels is reflected in the urine]. MMW Fortschr Med; 2008 Oct; 150(40):18. PubMed ID: 18990880 [No Abstract] [Full Text] [Related]
18. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
19. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178 [TBL] [Abstract][Full Text] [Related]